COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,395 Articles (22,816 medRxiv, 8,579 bioRxiv)

Most recent first Previous |  Page 805: Articles 8041-8050  | Next

mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
Li, R., Liu, H., Fairley, C. K., Ong, J. J., Guo, Y., Zou, Z., Xie, L., Zhuang, G., Li, Y., Shen, M., Zhang, L.
10.1101/2022.05.08.22274797 — Posted: 2022-05-10
10.4 Million Children Affected by COVID-19-associated Orphanhood and Caregiver Death: An Imperative for Action
Hillis, S., Ntwali N'konzi, J.-P., Msemburi, W., Cluver, L., Villaveces, A., Flaxman, S., Unwin, H. J. T.
10.1101/2022.05.08.22274788 — Posted: 2022-05-10
Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Martin Orozco, N., Vale, N., Mihic, A., Amor, T., Reiter, L., Arita, Y., Samson, R., Hu, Q., Gingras, A.-C., Sorenson, B., Marcusson, E., Patel, P.
10.1101/2022.05.06.22274690 — Posted: 2022-05-10
Association between environmental levels of PM2.5 and mortality from SARS-CoV-2 in inhabitants of Mexico City
Moreno-Santillan, A. A., Rivas-Ruiz, R., Fuentes-Valdivieso, R., Roy-Garcia, I. A.
10.1101/2022.05.08.22274818 — Posted: 2022-05-10
Decision trees for COVID-19 prognosis learned from patient data: Desaturating the ER with Artificial Intelligence
Bernaola, N., De Lima, G., Riano, M., Llanos, L., Heili-Frades, S., Sanchez, O., Lara, A., Plaza, G., Carballo, C., Gallego, P., Larranaga, P., Bielza, C.
10.1101/2022.05.09.22274832 — Posted: 2022-05-10
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., Addetia, A., Bowen, J. E., Stewart, C., Giurdanella, M., Saliba, C., Guarino, B., Schmid, M., Franko, N., Logue, J., Dang, H. V., di Iulio, J., Rivera, W., Schnell, G., Lempp, F., Janer, J., Abdelnabi, R., Maes, P., Ferrari, P., Ceschi, A., Giannini, O., de Melo, G., Kergoat, L., Bourhy, H., Neyts, J., Soriagha, L., Purcell, L., Snell, G., Whelan, S., Lanzavecchia, A., Virgin, H., Piccoli, L., Chu, H., Pizzuto, M. S., Corti, D., Veesler, D.
10.1101/2022.05.08.491108 — Posted: 2022-05-10
A New Paper Framework to Increase Reproducibility: Example Relating to Web Pharmacovigilance During COVID-19 in Italy
Rovetta, A., Castaldo, L.
10.1101/2022.05.03.22274607 — Posted: 2022-05-10
Adenovirus-Vectored SARS-CoV-2 Vaccine Expressing S1-N Fusion Protein
Khan, M. S., Kim, E., McPherson, A., Weisel, F. J., Huang, S., Kenniston, T. W., Percivalle, E., Gambotto, A., Baldanti, F., Meisel, M.
10.1101/2022.05.09.491179 — Posted: 2022-05-10
Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection
Jankowiak, M., Obermeyer, F. H., Lemieux, J.
10.1101/2022.05.07.490748 — Posted: 2022-05-10
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
Meng, B., Datir, R., Choi, J., CITIID-NIHR BioResource COVID-19 Collaboration, , Bradley, J., Smith, K. G., Lee, J. H., Gupta, R. K.
10.1101/2022.05.07.491004 — Posted: 2022-05-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).